Previous studies have reported EGFR mutation rates in young lung cancer ranging from 32% to 46.9%, and ALK rearrangement rates from 6.3% to 19%, which are consistent with those reported in this study [11,12,13,14,15]. Here, ALK is linked to lung cancer.